How big is the Global Antibody Drug Conjugates Market?

The Global Antibody Drug Conjugates Market size is estimated to have a value of USD 13.7 billion in 2024 and is expected to reach USD 51.2 billion by the end of 2033.

What is the size of the US Antibody Drug Conjugates Market?

The US Antibody Drug Conjugates market is projected to be valued at USD 4.9 billion in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 17.1 billion in 2033 at a CAGR of 14.8%.

Which region accounted for the largest Global Antibody Drug Conjugates Market?

North America is expected to have the largest market share in the Global Antibody Drug Conjugates Market with a share of about 42.7% in 2024.

Who are the key players in the Global Antibody Drug Conjugates Market?

Some of the major key players in the Global Antibody Drug Conjugates Market are Hoffmann-La Roche Ltd., Pfizer Inc., AstraZeneca, Gilead Sciences Inc., Astellas Pharma Inc., Seagen Inc., Daiichi Sankyo Company Limited, and many others.

What is the growth rate in the Global Antibody Drug Conjugates Market?

The market is growing at a CAGR of 15.8 percent over the forecasted period.

Antibody Drug Conjugates Market Size, Share, Trends and Forecast 2033

Antibody Drug Conjugates Market

Antibody Drug Conjugates Market By Product (KADCYLA, ENHERTU, ADCETRIS, PADCEV. TRODELVY, POLIVY, and Other Products), By Target Type, By Technology, By Payload Type, By Application, By End-User - Global Industry Outlook, Key Companies (Hoffmann-La Roche Ltd., Pfizer Inc., AstraZeneca and others), Trends and Forecast 2024-2033

Last Updated: July-2024

Report Code: RC-1040

Category: Pharmaceuticals & Healthcare

Pages: 278

Format: PDF / PPT / Excel

Research Methodology

Dimension Market Research has a systematic, transparent, and precision-driven research methodology designed to deliver accurate and reliable market intelligence. Primary Research forms the foundation of our approach, involving structured interviews and consultations with senior executives, product leaders, distributors, regulators, and subject-matter experts. This enables us to capture real-time market insights, emerging trends, growth opportunities, and critical challenges that are not readily available through public sources.
Our Primary Research is strengthened by robust Secondary Research. Our desk research process includes analysis of company filings, industry association publications, government and regulatory databases, and premium data sources. These sources support market sizing, competitive benchmarking, regulatory analysis, and historical trend assessment, forming a strong data-driven foundation for our research outputs.

Antibody Drug Conjugates Market

Research Methodology

Short Intro for Research Methodology

Research Approach & Execution

Why Dimension Market Research Is the Smart Choice for Your Business

Our Methodology and Market Approach

Our Research Data Sources